These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35065132)

  • 1. TSLP Impairs Epidermal Barrier Integrity by Stimulating the Formation of Nuclear IL-33/Phosphorylated STAT3 Complex in Human Keratinocytes.
    Dai X; Muto J; Shiraishi K; Utsunomiya R; Mori H; Murakami M; Sayama K
    J Invest Dermatol; 2022 Aug; 142(8):2100-2108.e5. PubMed ID: 35065132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear IL-33 Plays an Important Role in IL-31‒Mediated Downregulation of FLG, Keratin 1, and Keratin 10 by Regulating Signal Transducer and Activator of Transcription 3 Activation in Human Keratinocytes.
    Dai X; Shiraishi K; Muto J; Utsunomiya R; Mori H; Murakami M; Sayama K
    J Invest Dermatol; 2022 Jan; 142(1):136-144.e3. PubMed ID: 34293350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes.
    Dai X; Utsunomiya R; Shiraishi K; Mori H; Muto J; Murakami M; Sayama K
    J Invest Dermatol; 2021 Nov; 141(11):2646-2655.e6. PubMed ID: 33865911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes.
    Ryu WI; Lee H; Bae HC; Jeon J; Ryu HJ; Kim J; Kim JH; Son JW; Kim J; Imai Y; Yamanishi K; Jeong SH; Son SW
    J Dermatol Sci; 2018 Jun; 90(3):313-322. PubMed ID: 29534857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phellopterin alleviates atopic dermatitis-like inflammation and suppresses IL-4-induced STAT3 activation in keratinocytes.
    Chen X; Zhang Y; Pei J; Zeng X; Yang Y; Zhang Y; Li F; Deng Y
    Int Immunopharmacol; 2022 Nov; 112():109270. PubMed ID: 36179418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal keratinocyte-specific STAT3 deficiency aggravated atopic dermatitis-like skin inflammation in mice through TSLP upregulation.
    Wang ZY; Zheng YX; Xu F; Cui YZ; Chen XY; Chen SQ; Yan BX; Zhou Y; Zheng M; Man XY
    Front Immunol; 2023; 14():1273182. PubMed ID: 38053996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSLP Down-Regulates S100A7 and ß-Defensin 2 Via the JAK2/STAT3-Dependent Mechanism.
    Lee H; Ryu WI; Kim HJ; Bae HC; Ryu HJ; Shin JJ; Song KH; Kim TW; Son SW
    J Invest Dermatol; 2016 Dec; 136(12):2427-2435. PubMed ID: 27498343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterregulation between thymic stromal lymphopoietin- and IL-23-driven immune axes shapes skin inflammation in mice with epidermal barrier defects.
    Li J; Leyva-Castillo JM; Hener P; Eisenmann A; Zaafouri S; Jonca N; Serre G; Birling MC; Li M
    J Allergy Clin Immunol; 2016 Jul; 138(1):150-161.e13. PubMed ID: 26993035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocytes in atopic dermatitis express abundant ΔNp73 regulating thymic stromal lymphopoietin production via NF-κB.
    Kumagai A; Kubo T; Kawata K; Kamekura R; Yamashita K; Jitsukawa S; Nagaya T; Sumikawa Y; Himi T; Yamashita T; Ichimiya S
    J Dermatol Sci; 2017 Nov; 88(2):175-183. PubMed ID: 28655470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway.
    Du HY; Fu HY; Li DN; Qiao Y; Wang QW; Liu W
    J Interferon Cytokine Res; 2016 Sep; 36(9):552-62. PubMed ID: 27348082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.
    Wang Z; Zhang LJ; Guha G; Li S; Kyrylkova K; Kioussi C; Leid M; Ganguli-Indra G; Indra AK
    PLoS One; 2012; 7(12):e51262. PubMed ID: 23284675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 induces Egr-1-dependent TSLP expression via the MAPK pathways in human keratinocytes.
    Ryu WI; Lee H; Kim JH; Bae HC; Ryu HJ; Son SW
    Exp Dermatol; 2015 Nov; 24(11):857-63. PubMed ID: 26120956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.
    Brewer MG; Yoshida T; Kuo FI; Fridy S; Beck LA; De Benedetto A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions.
    Wang X; Jiang X; Yu X; Liu H; Tao Y; Jiang G; Hong M
    J Cell Mol Med; 2017 Nov; 21(11):2926-2936. PubMed ID: 28597545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling.
    Dao TTP; Song K; Kim JY; Kim YS
    Inflamm Res; 2020 Mar; 69(3):309-319. PubMed ID: 32002586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.
    Kamsteeg M; Bergers M; de Boer R; Zeeuwen PL; Hato SV; Schalkwijk J; Tjabringa GS
    Am J Pathol; 2011 May; 178(5):2091-9. PubMed ID: 21514424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33 in atopic dermatitis.
    Imai Y
    J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E
    Sawada Y; Honda T; Nakamizo S; Nakajima S; Nonomura Y; Otsuka A; Egawa G; Yoshimoto T; Nakamura M; Narumiya S; Kabashima K
    J Allergy Clin Immunol; 2019 Nov; 144(5):1265-1273.e9. PubMed ID: 31301371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently.
    Bergmann S; von Buenau B; Vidal-Y-Sy S; Haftek M; Wladykowski E; Houdek P; Lezius S; Duplan H; Bäsler K; Dähnhardt-Pfeiffer S; Gorzelanny C; Schneider SW; Rodriguez E; Stölzl D; Weidinger S; Brandner JM
    Sci Rep; 2020 Feb; 10(1):2024. PubMed ID: 32029783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYT387, a Novel JAK2 Inhibitor, Suppresses IL-13-Induced Epidermal Barrier Dysfunction Via miR-143 Targeting IL-13Rα1 and STAT3.
    Zu Y; Chen XF; Li Q; Zhang ST
    Biochem Genet; 2021 Apr; 59(2):531-546. PubMed ID: 33190168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.